MO
45
-2
FE
62
2
NTAP
46
3
GS
62
3
FSLR
49
-3
DRI
45
5
NI
75
3
GME
55
3
HIG
54
-8
SRE
68
2
ORLY
58
8
FFIV
52
3
BEN
55
-2
PEG
36
2
V
40
4
PGR
40
3
RF
61
3
CSCO
57
3
CMG
41
3
MLM
50
2
MO
45
-2
FE
62
2
NTAP
46
3
GS
62
3
FSLR
49
-3
DRI
45
5
NI
75
3
GME
55
3
HIG
54
-8
SRE
68
2
ORLY
58
8
FFIV
52
3
BEN
55
-2
PEG
36
2
V
40
4
PGR
40
3
RF
61
3
CSCO
57
3
CMG
41
3
MLM
50
2
Financhill
Back

Virtus Seix Senior Loan ETF Vs. Celldex Therapeutics, Inc. Sector Stock Comparison

Sell
29

SEIX
Virtus Seix Senior Loan ETF

Last Price:
$23.02
Seasonality Move:
0.73%
Sell
48

CLDX
Celldex Therapeutics, Inc.

Last Price:
$31.05
Seasonality Move:
20.93%
Sell
29
Virtus Seix Senior Loan ETF (SEIX) is a Sell

Is Virtus Seix Senior Loan ETF a Buy, Sell or Hold?

  • The current Virtus Seix Senior Loan ETF [SEIX] share price is $23.04. The Score for SEIX is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • SEIX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Celldex Therapeutics, Inc. (CLDX) is a Sell

Is Celldex Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Celldex Therapeutics, Inc. [CLDX] share price is $31.05. The Score for CLDX is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • CLDX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

SEIX Stock Price Chart

What is Virtus Seix Senior Loan ETF's stock price today?

  • The Virtus Seix Senior Loan ETF share price today is $23.04
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SEIX is experiencing slight buying pressure.

CLDX Stock Price Chart

What is Celldex Therapeutics, Inc.'s stock price today?

  • The Celldex Therapeutics, Inc. share price today is $31.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CLDX is experiencing buying pressure, which is a positive indicator for future bullish movement.

SEIX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 43.77 Sell
Chaikin Money Flow: 13000 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (23.01 - 23.13) Sell
Bollinger Bands (100): (23.12 - 23.44) Sell

CLDX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.9 Buy
Relative Strength Index (14 RSI): 55.97 Buy
Chaikin Money Flow: 3988094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (29.43 - 31.31) Buy
Bollinger Bands (100): (24.48 - 29.54) Buy

SEIX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.04 Sell
20-day SMA: 23.09 Sell
50-day SMA: 23.15 Sell
200-day SMA: 23.43 Sell
8-day EMA: 23.05 Sell
20-day EMA: 23.07 Sell
50-day EMA: 23.15 Sell
200-day EMA: 23.38 Sell

CLDX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 31.05 Buy
20-day SMA: 30.57 Buy
50-day SMA: 27.66 Buy
200-day SMA: 25.4 Buy
8-day EMA: 30.94 Buy
20-day EMA: 30.26 Buy
50-day EMA: 28.67 Buy
200-day EMA: 26.26 Buy

Virtus Seix Senior Loan ETF Earnings Growth & SEIX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Celldex Therapeutics, Inc. Earnings Growth & CLDX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.35 per share, a decrease next quarter of $0.20 per share, a decrease this year of $1.19 per share, and an increase next year of $0.04 per share.

Virtus Seix Senior Loan ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Celldex Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):